At Elixir Pharma, we are proud to partner with Hetero, one of the world’s leading producers of Active Pharmaceutical Ingredients (APIs) and generic formulations.
With a presence in over 140 countries and more than 30 years of experience, Hetero has established itself as a trusted global pharmaceutical leader.

This strategic alliance is built on a shared commitment to transforming science and technology into real-world therapies that improve health outcomes and elevate quality of life.
Together, we have established a state-of-the-art manufacturing facility, a symbol of our joint dedication to operational excellence, innovation, and high-quality treatments for the communities we serve.

• Dr. B. Parthasaradhi Reddy, Chairman of Hetero Group of Companies, has been instrumental in shaping the organization into a world-class leader that prioritizes innovation, quality, and accessibility in healthcare.

• Dr. Vamsi Krishna Bandi, Managing Director, continues to expand Hetero’s frontiers by championing sustainable practices and patient-centric strategies that meet today’s evolving healthcare needs.

• Mr. Murali Krishna Reddy, Director of Emerging Markets and India, plays a pivotal role in advancing Hetero’s mission and operational excellence.

Together, this leadership team embodies the principles of responsibility, collaboration, and relentless pursuit of progress—values that deeply resonate with us at Elixir Pharma.

By uniting purpose with partnership, we are not only expanding our reach, but also our impact—building a healthier tomorrow for all.